-
sodium (4aR,6R,7R,7aS)-6-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-7-hydroxy-2-oxo-hexahydro-1,3,5,2λ5-furo[3,2-d][1,3,2λ5]dioxaphosphinin-2-olate
-
ChemBase ID:
132314
-
Molecular Formular:
C10H11N5NaO7P
-
Molecular Mass:
367.187171
-
Monoisotopic Mass:
367.02937863
-
SMILES and InChIs
SMILES:
c1nc2c(=O)[nH]c(nc2n1[C@H]1[C@@H]([C@H]2[C@H](O1)COP(=O)(O2)[O-])O)N.[Na+]
Canonical SMILES:
O[C@@H]1[C@@H]2OP(=O)([O-])OC[C@H]2O[C@H]1n1cnc2c1nc(N)[nH]c2=O.[Na+]
InChI:
InChI=1S/C10H12N5O7P.Na/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6-3(21-9)1-20-23(18,19)22-6;/h2-3,5-6,9,16H,1H2,(H,18,19)(H3,11,13,14,17);/q;+1/p-1/t3-,5-,6-,9-;/m1./s1
InChIKey:
KMPIYXNEROUNOG-GWTDSMLYSA-M
-
Cite this record
CBID:132314 http://www.chembase.cn/molecule-132314.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
sodium (4aR,6R,7R,7aS)-6-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-7-hydroxy-2-oxo-hexahydro-1,3,5,2λ5-furo[3,2-d][1,3,2λ5]dioxaphosphinin-2-olate
|
|
|
IUPAC Traditional name
|
sodium 3',5'-cyclic gmp anion
|
|
|
Synonyms
|
3′,5′-Cyclic GMP monosodium salt
|
3′,5′-cGMP-Na
|
Guanosine 3′,5′-cyclophosphate monosodium salt
|
cGMP
|
cyclic GMP
|
Guanosine 3′,5′-cyclic monophosphate sodium salt
|
Guanosine Cyclic 3',5'-(Hydrogen phosphate) Sodium Salt
|
Cyclic 3',5'-Guanosine Monophosphate Monosodium Salt
|
Guanosine Monophosphate Monosodium Salt
|
Monosodium-GMP
|
Guanosine 3',5'-Cyclic Monophosphate Sodium Salt
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
Beilstein Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
2.0500584
|
H Acceptors
|
8
|
H Donor
|
3
|
LogD (pH = 5.5)
|
-4.2590003
|
LogD (pH = 7.4)
|
-4.309573
|
Log P
|
-2.0959094
|
Molar Refractivity
|
70.5933 cm3
|
Polarizability
|
27.621025 Å3
|
Polar Surface Area
|
173.35 Å2
|
Rotatable Bonds
|
1
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
TRC
Sigma Aldrich -
G6129
|
Biochem/physiol Actions An important second messenger, cGMP is a major intracellular mediator of extracellular signals such as nitric oxide and natriuretic peptides. Cyclic GMP interacts with three types of intracellular receptor proteins: cGMP-dependent protein kinases, cGMP-regulated channels, and cGMP-regulated cyclic nucleotide phosphodiesterases. A primary action of elevated cGMP levels in vivo is the stimulation of cGMP-dependent protein kinase (PKG). |
Sigma Aldrich -
51055
|
Biochem/physiol Actions An important second messenger, cGMP is a major intracellular mediator of extracellular signals such as nitric oxide and natriuretic peptides. Cyclic GMP interacts with three types of intracellular receptor proteins: cGMP-dependent protein kinases, cGMP-regulated channels, and cGMP-regulated cyclic nucleotide phosphodiesterases. A primary action of elevated cGMP levels in vivo is the stimulation of cGMP-dependent protein kinase (PKG). |
PATENTS
PATENTS
PubChem Patent
Google Patent